FPRX - Five Prime Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Five Prime Therapeutics's activity chart (see below) currently has 42 price targets and 44 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.33% with an average time for these price targets to be met of 383.15 days.

Most recent stock forecast was given by from BARCLAYS on 09-Mar-2021. First documented stock forecast 24-Nov-2014.

Best performing analysts who are covering FPRX - Five Prime Therapeutics:

Christopher Marai Jim Birchenough Kennen Mackay Robert Driscoll Michael Schmidt Tony Butler

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Mar-2021

$38

$11

5 years 6 months 12 days ago
(09-Mar-2021)

2/2 (100%)

$0.1 (0.26%)

44

Buy Since 08-Mar-2021

$38

5 years 6 months 13 days ago
(08-Mar-2021)

4/4 (100%)

$0.24 (0.64%)

252

Buy Since 15-Apr-2015

$38

$52

5 years 6 months 16 days ago
(05-Mar-2021)

3/4 (75%)

$0.24 (0.64%)

116

Buy Since 18-Feb-2020

$28

$-10 (-26.32%)

$28

5 years 6 months 17 days ago
(04-Mar-2021)

4/5 (80%)

$-10 (-26.32%)

405

Buy Since 11-Nov-2020

$30

$-8 (-21.05%)

$30

5 years 6 months 17 days ago
(04-Mar-2021)

3/4 (75%)

$-8 (-21.05%)

301

Show more analysts

Please expand the browser size to see the chart

What is FPRX (Five Prime Therapeutics) average time for price targets to be met?

On average it took 383 days for the stock forecasts to be reached, with an average price target met ratio of 71.33%.

Which analyst most recently updated their price target on FPRX (Five Prime Therapeutics)?

Which analyst has the most public recommendations on FPRX (Five Prime Therapeutics)?

has 0 price targets and 0 ratings on FPRX

Which analyst is the currently most bullish on FPRX (Five Prime Therapeutics)?

Kennen Mackay with the highest potential upside of $12

Which analyst is the currently most reserved on FPRX (Five Prime Therapeutics)?

Christopher Marai with the lowest potential downside of -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?